DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)



company name or ticker

The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Relea

The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Releases

3 Biotech Stocks Still Attractive After Monday's Sell-Off - Analyst Blog

Is Alnylam In 2020 Worth $9 Billion Now?

InsiderInsights.com Daily Round Up 4/23/15: GE, OMN, COCP, AGCO

The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases

Use Options For a Chance To Buy ALNY at a 32% Discount

Alnylam Strengthens Its Clinical Case Once Again

Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog

Why Alnylam Pharmaceuticals, Inc. Shares Are Soaring Today

Alnylam Pharmaceuticals, Inc. has reported positive phase 2 results for patisiran.
See More Articles...